Therapeutic Hydroxychloroquine Blood Levels Are Associated With Fewer Hospitalizations and Possible Reduction of Health Disparities in Lupus
HCQ blood levels within 750 to 1,200 ng/mL are associated with lower rates of acute care in all patients with lupus, including groups with higher rates of acute care. Future clinical trials should establish the causal association between HCQ level monitoring and acute care in patients with lupus.
Authors
- Brad C. Astor (ORCID: https://orcid.org/0000-0002-0876-0069)
- Betty Chewning (ORCID: https://orcid.org/0000-0003-1686-2329)
- Christie M. Bartels (ORCID: https://orcid.org/0000-0001-6523-0374)
- Giancarlo R. Valiente (ORCID: https://orcid.org/0000-0002-2453-2891)
- Shivani Garg (ORCID: https://orcid.org/0000-0001-7272-2692)
- Lexie Kolton
- Callie Saric (ORCID: https://orcid.org/0009-0003-8034-4873)
Institutions
- University of Wisconsin–Madison (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1002/acr.25422
- Citations
- 10
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 4.70
Funders
- Lupus Foundation of America
- Institute for Clinical and Translational Research, University of Wisconsin, Madison